Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients

Figure 3

Combination effect of SAHA and paclitaxel on ovarian cancer cells. Four hours after treatment with SAHA, OVCAR-3 and SK-OV-3 cells were exposed to paclitaxel for further 72 hours. Cytotoxic effects were assessed by Alamar Blue assay. Cell viabilities are expressed as the ratio of absorbance of treated to untreated cells. Means ± SD of 3 independent experiments in quadruplicates are shown.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us